HIV and HCV Intervention In Drug Treatment Settings - 1

HIV and HCV Intervention in Drug Treatment Settings

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00102349

Enrollment

706

Registered

2005-01-28

Start date

2004-11-30

Completion date

2006-02-28

Last updated

2017-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behavior Therapy

Keywords

behavioral intervention

Brief summary

The purpose of this study is to test two strategies to reduce the risk of contracting Human Immunodeficiency Virus (HIV) or Hepatitis C Virus (HCV) by reducing risk behaviors in patients undergoing drug detoxification.

Interventions

BEHAVIORALBehavior Therapy

Study design

Primary purpose

PREVENTION

Eligibility

Sex/Gender

ALL

Age

18 Years to 99 Years

Healthy volunteers

Inclusion criteria

Volunteers will be IV drug users already enrolled in drug detoxification treatment.

Design outcomes

Primary

Measure	Time frame
HIV/HCV injection risk behaviors	—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026